← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA Symposium.

Kristin M Wessel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41481339